Works matching DE "RITONAVIR"
Results: 1062
Nirmatrelvir plus ritonavir in COVID-19: a profile of its use.
- Published in:
- Drugs & Therapy Perspectives, 2023, v. 39, n. 2, p. 41, doi. 10.1007/s40267-022-00971-1
- By:
- Publication type:
- Article
Electrophysiological features and multimodal imaging in ritonavir-related maculopathy.
- Published in:
- Documenta Ophthalmologica, 2017, v. 135, n. 3, p. 241, doi. 10.1007/s10633-017-9612-z
- By:
- Publication type:
- Article
Hydroxychloroquine and ritonavir for COVID-19 infection: a possible synergic toxicity for retinal pigmented epithelium.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Pharmacokinetics of nirmatrelvir/ritonavir and the drug-drug interaction with calcineurin inhibitor in renal transplant recipients.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 8, p. 1219, doi. 10.1007/s00228-024-03691-9
- By:
- Publication type:
- Article
COVID-19 and antiepileptic drugs: an approach to guide practices when nirmatrelvir/ritonavir is co-prescribed.
- Published in:
- European Journal of Clinical Pharmacology, 2022, v. 78, n. 10, p. 1697, doi. 10.1007/s00228-022-03370-7
- By:
- Publication type:
- Article
Evaluation of the effects of atazanavir-ritonavir on the pharmacokinetics of lumefantrine in patients living with HIV in Lagos University Teaching Hospital, South-Western Nigeria.
- Published in:
- European Journal of Clinical Pharmacology, 2021, v. 77, n. 9, p. 1341, doi. 10.1007/s00228-021-03116-x
- By:
- Publication type:
- Article
Optimal sampling strategies for darunavir and external validation of the underlying population pharmacokinetic model.
- Published in:
- European Journal of Clinical Pharmacology, 2021, v. 77, n. 4, p. 607, doi. 10.1007/s00228-020-03036-2
- By:
- Publication type:
- Article
Effects of chronic kidney disease stage 4, end-stage renal disease, or dialysis on the plasma concentrations of ombitasvir, paritaprevir, ritonavir, and dasabuvir in patients with chronic HCV infection: pharmacokinetic analysis of the phase 3 RUBY-I and RUBY-II trials
- Published in:
- European Journal of Clinical Pharmacology, 2019, v. 75, n. 2, p. 207, doi. 10.1007/s00228-018-2566-6
- By:
- Publication type:
- Article
Darunavir concentration in PBMCs may be a better indicator of drug exposure in HIV patients.
- Published in:
- European Journal of Clinical Pharmacology, 2018, v. 74, n. 8, p. 1055, doi. 10.1007/s00228-018-2464-y
- By:
- Publication type:
- Article
Application of physiologically based pharmacokinetic modeling to the prediction of drug-drug and drug-disease interactions for rivaroxaban.
- Published in:
- European Journal of Clinical Pharmacology, 2018, v. 74, n. 6, p. 755, doi. 10.1007/s00228-018-2430-8
- By:
- Publication type:
- Article
Effect of hepatitis B and C clearance on atazanavir exposure.
- Published in:
- 2015
- By:
- Publication type:
- Letter
Effects of enzyme inducers efavirenz and tipranavir/ritonavir on the pharmacokinetics of the HIV integrase inhibitor dolutegravir.
- Published in:
- European Journal of Clinical Pharmacology, 2014, v. 70, n. 10, p. 1173, doi. 10.1007/s00228-014-1732-8
- By:
- Publication type:
- Article
A randomised study of the effect of danoprevir/ritonavir or ritonavir on substrates of cytochrome P450 (CYP) 3A and 2C9 in chronic hepatitis C patients using a drug cocktail.
- Published in:
- European Journal of Clinical Pharmacology, 2013, v. 69, n. 11, p. 1939, doi. 10.1007/s00228-013-1556-y
- By:
- Publication type:
- Article
Concentration effect relationship of CYP3A inhibition by ritonavir in humans.
- Published in:
- European Journal of Clinical Pharmacology, 2013, v. 69, n. 10, p. 1795, doi. 10.1007/s00228-013-1530-8
- By:
- Publication type:
- Article
Long-term Follow-up Liver Stiffness Results of Chronic Hepatitis C Patients Treated with Direct-acting Antivirals.
- Published in:
- Journal of Tepecik Education & Research Hospital / İzmir Tepecik Eğitim ve Araştırma Hastanesi Dergisi, 2023, v. 33, n. 1, p. 76, doi. 10.4274/terh.galenos.2022.68736
- By:
- Publication type:
- Article
The comparison of favipiravir and lopinavir/ritonavir combination in COVID-19 treatment.
- Published in:
- Turkish Journal of Medical Sciences, 2021, v. 51, n. 4, p. 1624, doi. 10.3906/sag-2012-189
- By:
- Publication type:
- Article
Antiviral treatment of COVID-19.
- Published in:
- Turkish Journal of Medical Sciences, 2020, v. 50, n. SI, p. 611, doi. 10.3906/sag-2004-145
- By:
- Publication type:
- Article
Drug-drug interaction between ensitrelvir and tacrolimus in a patient undergoing treatment for COVID-19: a case report.
- Published in:
- Journal of Pharmaceutical Health Care & Sciences, 2025, v. 11, n. 1, p. 1, doi. 10.1186/s40780-025-00411-y
- By:
- Publication type:
- Article
Oral Nirmatrelvir/Ritonavir Therapy for COVID-19: The Dawn in the Dark?
- Published in:
- Antibiotics (2079-6382), 2022, v. 11, n. 2, p. 220, doi. 10.3390/antibiotics11020220
- By:
- Publication type:
- Article
Paxlovid (Nirmatrelvir and Ritonavir) Use in Pregnant and Lactating Woman: Current Evidence and Practice Guidelines—A Scoping Review.
- Published in:
- Vaccines, 2023, v. 11, n. 1, p. 107, doi. 10.3390/vaccines11010107
- By:
- Publication type:
- Article
Early combination treatment with existing HIV antivirals: an effective treatment for COVID-19?
- Published in:
- European Review for Medical & Pharmacological Sciences, 2021, v. 25, n. 5, p. 2435
- By:
- Publication type:
- Article
Reply Letter – “Safety and efficacy of oral lopinavir/ritonavir in pediatric patients with coronavirus disease: a nationwide comparative analysis”.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
Safety and efficacy of oral lopinavir/ritonavir in pediatric patients with coronavirus disease: a nationwide comparative analysis.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2021, v. 25, n. 1, p. 549
- By:
- Publication type:
- Article
A contemporary look at COVID-19 medications: available and potentially effective drugs.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2020, v. 24, n. 17, p. 9188
- By:
- Publication type:
- Article
Lopinavir/ritonavir for the treatment of SARS, MERS and COVID-19: a systematic review.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2020, v. 24, n. 16, p. 8592
- By:
- Publication type:
- Article
Secondary Adrenal Insufficiency Due to the Co-Administration of Ritonavir and Inhaled Fluticasone Propionate: Case report.
- Published in:
- Sultan Qaboos University Medical Journal, 2017, v. 17, n. 3, p. 339, doi. 10.18295/squmj.2017.17.03.014
- By:
- Publication type:
- Article
High Detection Rate of HIV Drug Resistance Mutations among Patients Who Fail Combined Antiretroviral Therapy in Manaus, Brazil.
- Published in:
- BioMed Research International, 2021, p. 1, doi. 10.1155/2021/5567332
- By:
- Publication type:
- Article
"Saving lives with nirmatrelvir/ritonavir one transplant patient at a time".
- Published in:
- Transplant Infectious Disease, 2023, v. 25, n. 2, p. 1, doi. 10.1111/tid.14037
- By:
- Publication type:
- Article
Nanomaterials for Photocatalytic Degradations of Analgesic, Mucolytic and Anti-Biotic/Viral/Inflammatory Drugs Widely Used in Controlling SARS-CoV-2.
- Published in:
- Catalysts (2073-4344), 2022, v. 12, n. 6, p. N.PAG, doi. 10.3390/catal12060667
- By:
- Publication type:
- Article
Efficacy and Safety of Anti-SARS-CoV-2 Antiviral Agents and Monoclonal Antibodies in Patients with SLE: A Case-Control Study.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 9, p. 1273, doi. 10.3390/biom13091273
- By:
- Publication type:
- Article
Significant improvement in triglyceride levels after switching from ritonavir to cobicistat in suppressed HIV-1-infected subjects with dyslipidaemia.
- Published in:
- HIV Medicine, 2017, v. 18, n. 10, p. 782, doi. 10.1111/hiv.12530
- By:
- Publication type:
- Article
Plasma trough concentrations of darunavir/ritonavir and raltegravir in older patients with HIV-1 infection.
- Published in:
- HIV Medicine, 2017, v. 18, n. 7, p. 474, doi. 10.1111/hiv.12478
- By:
- Publication type:
- Article
Week 96 efficacy and safety of darunavir/ritonavir monotherapy vs. darunavir/ritonavir with two nucleoside reverse transcriptase inhibitors in the PROTEA trial.
- Published in:
- HIV Medicine, 2017, v. 18, n. 1, p. 5, doi. 10.1111/hiv.12386
- By:
- Publication type:
- Article
Virological response and resistance profile in HIV-1-infected patients starting darunavir-containing regimens.
- Published in:
- HIV Medicine, 2017, v. 18, n. 1, p. 21, doi. 10.1111/hiv.12388
- By:
- Publication type:
- Article
Pharmacokinetics of once-daily darunavir/ritonavir in HIV-1-infected pregnant women.
- Published in:
- HIV Medicine, 2016, v. 17, n. 9, p. 643, doi. 10.1111/hiv.12366
- By:
- Publication type:
- Article
Rosuvastatin vs. protease inhibitor switching for hypercholesterolaemia: a randomized trial.
- Published in:
- HIV Medicine, 2016, v. 17, n. 8, p. 605, doi. 10.1111/hiv.12362
- By:
- Publication type:
- Article
PEPDar: A randomized prospective noninferiority study of ritonavir-boosted darunavir for HIV post-exposure prophylaxis.
- Published in:
- HIV Medicine, 2016, v. 17, n. 6, p. 453, doi. 10.1111/hiv.12363
- By:
- Publication type:
- Article
Efficacy of protease inhibitor monotherapy vs. triple therapy: meta-analysis of data from 2303 patients in 13 randomized trials.
- Published in:
- HIV Medicine, 2016, v. 17, n. 5, p. 358, doi. 10.1111/hiv.12348
- By:
- Publication type:
- Article
The Intelence aNd pRezista Once A Day Study ( INROADS): a multicentre, single-arm, open-label study of etravirine and darunavir/ritonavir as dual therapy in HIV-1-infected early treatment-experienced subjects.
- Published in:
- HIV Medicine, 2015, v. 16, n. 5, p. 288, doi. 10.1111/hiv.12211
- By:
- Publication type:
- Article
Low concordance and resistance mutation emergence in the HIV protease gene among circulating and cell-associated viruses at viral replication episodes during darunavir/ritonavir monotherapy.
- Published in:
- HIV Medicine, 2015, v. 16, n. 1, p. 57, doi. 10.1111/hiv.12170
- By:
- Publication type:
- Article
Therapeutic drug monitoring of atazanavir/ritonavir in pregnancy.
- Published in:
- HIV Medicine, 2014, v. 15, n. 10, p. 604, doi. 10.1111/hiv.12164
- By:
- Publication type:
- Article
Interpreting the reasons for the choice and changing of two drug regimens in an observational cohort: comparison of a ritonavir-boosted protease inhibitor-based versus a nonnucleoside reverse transcriptase inhibitor-based first-line regimen.
- Published in:
- HIV Medicine, 2014, v. 15, n. 9, p. 547, doi. 10.1111/hiv.12144
- By:
- Publication type:
- Article
Pharmacokinetics and efficacy of darunavir/ritonavir once daily in virologically suppressed, treatment-experienced HIV-infected children.
- Published in:
- HIV Medicine, 2014, v. 15, n. 8, p. 511, doi. 10.1111/hiv.12163
- By:
- Publication type:
- Article
Efficacy and safety of once-daily maraviroc plus ritonavir-boosted darunavir in pretreated HIV-infected patients in a real-life setting.
- Published in:
- HIV Medicine, 2014, v. 15, n. 7, p. 417, doi. 10.1111/hiv.12129
- By:
- Publication type:
- Article
A meta-analysis of the efficacy and safety of unboosted atazanavir compared with ritonavir-boosted protease inhibitor maintenance therapy in HIV-infected adults with established virological suppression after induction.
- Published in:
- HIV Medicine, 2014, v. 15, n. 5, p. 301, doi. 10.1111/hiv.12118
- By:
- Publication type:
- Article
Total and unbound darunavir pharmacokinetics in pregnant women infected with HIV-1: results of a study of darunavir/ritonavir 600/100 mg administered twice daily.
- Published in:
- HIV Medicine, 2014, v. 15, n. 1, p. 50, doi. 10.1111/hiv.12047
- By:
- Publication type:
- Article
Pharmacokinetic interaction between etravirine or darunavir/ritonavir and artemether/lumefantrine in healthy volunteers: a two-panel, two-way, two-period, randomized trial.
- Published in:
- HIV Medicine, 2013, v. 14, n. 7, p. 421, doi. 10.1111/hiv.12019
- By:
- Publication type:
- Article
Subgroup analysis of virological response rates with once- and twice-daily darunavir/ritonavir in treatment-experienced patients without darunavir resistance-associated mutations in the ODIN trial.
- Published in:
- HIV Medicine, 2013, v. 14, n. 7, p. 437, doi. 10.1111/hiv.12024
- By:
- Publication type:
- Article
Pharmacokinetics of two common antiretroviral regimens in older HIV-infected patients: a pilot study Pharmacokinetics of two common antiretroviral regimens in older HIV-infected patients: a pilot study.
- Published in:
- HIV Medicine, 2013, v. 14, n. 7, p. 401, doi. 10.1111/hiv.12017
- By:
- Publication type:
- Article
Final 192-week efficacy and safety of once-daily darunavir/ritonavir compared with lopinavir/ritonavir in HIV-1-infected treatment-naïve patients in the ARTEMIS trial Final 192-week efficacy and safety of once-daily darunavir/ritonavir compared with lopinavir/ritonavir in HIV-1-infected treatment-naïve patients in the ARTEMIS trial
- Published in:
- HIV Medicine, 2013, v. 14, n. 1, p. 49, doi. 10.1111/j.1468-1293.2012.01060.x
- By:
- Publication type:
- Article